These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 30368864)
1. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with cyclosporin A. Thijs JL; Drylewicz J; Bruijnzeel-Koomen CAFM; Giovannone B; Knol EF; de Bruin-Weller MS; Nierkens S; Hijnen D Allergy; 2019 Mar; 74(3):613-617. PubMed ID: 30368864 [No Abstract] [Full Text] [Related]
2. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index. Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402 [TBL] [Abstract][Full Text] [Related]
4. A Monocentric Retrospective Cohort of Patients with Severe Atopic Dermatitis Treated with Cyclosporine A in Daily Practice. Daguzé J; Aubert H; Bernier C; Gaultier A; Nguyen JM; Stalder JF; Barbarot S Acta Derm Venereol; 2017 Aug; 97(8):955-956. PubMed ID: 28448098 [No Abstract] [Full Text] [Related]
5. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers. Bakker DS; Ariens LFM; Giovannone B; Hijnen D; Delemarre EM; Knol E; Nierkens S; de Bruin-Weller MS; Thijs JL; Drylewicz J Allergy; 2020 Dec; 75(12):3287-3289. PubMed ID: 33305359 [No Abstract] [Full Text] [Related]
6. Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. Barbier N; Paul C; Luger T; Allen R; De Prost Y; Papp K; Eichenfield LF; Cherill R; Hanifin J Br J Dermatol; 2004 Jan; 150(1):96-102. PubMed ID: 14746622 [TBL] [Abstract][Full Text] [Related]
7. Influence of food intake on the clinical response to cyclosporin A in canine atopic dermatitis. Thelen A; Mueller RS; Linek M; Peters S; Stechmann K; Steffan J Vet Rec; 2006 Dec; 159(25):854-6. PubMed ID: 17172483 [No Abstract] [Full Text] [Related]
8. EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab. Olydam JI; de Wijs LEM; Dik WA; Røpke MA; Da Rosa JC; Hijnen DJ J Invest Dermatol; 2022 Dec; 142(12):3335-3337.e1. PubMed ID: 35843313 [No Abstract] [Full Text] [Related]
9. Pseudotumor cerebri associated with cyclosporine use in severe atopic dermatitis. Blasco Morente G; Tercedor Sánchez J; Garrido Colmenero C; Martínez García E; Molina-Carballo A Pediatr Dermatol; 2015; 32(2):237-9. PubMed ID: 24330027 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporin in atopic dermatitis: review of the literature and outline of a Belgian consensus. Naeyaert JM; Lachapelle JM; Degreef H; de la Brassinne M; Heenen M; Lambert J Dermatology; 1999; 198(2):145-52. PubMed ID: 10325461 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporin treatment of atopic dermatitis: five case studies and literature review. Stephens RB; Lee ML; Cooper A Australas J Dermatol; 1994; 35(2):55-9. PubMed ID: 7702488 [TBL] [Abstract][Full Text] [Related]
15. Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A. Reinhard T; Möller M; Sundmacher R Cornea; 1999 Nov; 18(6):645-51. PubMed ID: 10571292 [TBL] [Abstract][Full Text] [Related]
16. [Cyclosporin in atopic dermatitis]. Pacor ML; Biasi D; Di Lorenzo G; Carletto A; Corrocher R Recenti Prog Med; 2001 Jun; 92(6):390-1. PubMed ID: 11433717 [TBL] [Abstract][Full Text] [Related]
17. The future is finally here: Advances in the treatment of atopic dermatitis. Zirwas MJ J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S25-S27. PubMed ID: 29248517 [No Abstract] [Full Text] [Related]
18. Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial. Goujon C; Viguier M; Staumont-Sallé D; Bernier C; Guillet G; Lahfa M; Ferrier Le Bouedec MC; Cambazard F; Bottigioli D; Grande S; Dahel K; Bérard F; Rabilloud M; Mercier C; Nicolas JF J Allergy Clin Immunol Pract; 2018; 6(2):562-569.e3. PubMed ID: 28967549 [TBL] [Abstract][Full Text] [Related]
19. [How should severe and chronic atopic dermatitis be managed in children?]. Bernier C Ann Dermatol Venereol; 2005 Jan; 132 Spec No 1():1S267-81. PubMed ID: 15984312 [No Abstract] [Full Text] [Related]
20. Topical Tacrolimus versus Hydrocortisone on Atopic Dermatitis in Paediatric Patients: A Randomized Controlled Trial. Rahman MF; Nandi AK; Kabir S; Kamal M; Basher MS; Banu LA Mymensingh Med J; 2015 Jul; 24(3):457-63. PubMed ID: 26329939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]